
Despite Encouraging Results, Several Uncertainties Surround an Investigational Alzheimer’s Treatment, According to Specialists
Lecanemab, an investigational medication for Alzheimer’s, made headlines last week when the company studying it disclosed trial findings demonstrating that the treatment achieved its objectives,…










